Active Ingredient History
Lipopolysaccharides (LPS) are large molecules consisting of a lipid and a polysaccharide composed of O-antigen, outer core and inner core joined by a covalent bond; they are found in the outer membrane of Gram-negative bacteria. The term lipooligosaccharide ("LOS") is used to refer to a low-molecular-weight form of bacterial lipopolysaccharides. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Alzheimer Disease (Early Phase 1)
Arthritis, Rheumatoid (Phase 1)
Asthma (Phase 1)
Autoimmune Diseases (Early Phase 1)
Cannabidiol (Phase 1)
Cardiovascular Diseases (Phase 1)
Depression (Early Phase 1)
Depressive Disorder, Major (Phase 1/Phase 2)
Endotoxemia (Phase 4)
Healthy Volunteers (Phase 4)
Hyperoxia (Phase 1/Phase 2)
Hypoxia (Phase 1/Phase 2)
Immunity, Innate (Phase 1)
Infections (Early Phase 1)
Inflammation (Phase 1)
Lung Diseases (Phase 1)
Melanoma (Phase 1)
Oxygen Saturation (Phase 2)
Schizophrenia (Phase 1)
Sepsis (Phase 2/Phase 3)
Stress Disorders, Post-Traumatic (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue